
Unresectable Colon Cancer with Charles Fuchs, MD and Tanios Bekaii-Saab, MD

Unresectable Colon Cancer with Charles Fuchs, MD and Tanios Bekaii-Saab, MD














ER+/HER2-Breast Cancer with Adam Brufsky, MD, PhD and Kimberly Blackwell, MD









Michael Manns, MD, explains the possible link between hepatitis C and hepatocellular carcinoma.

Anne Covey, MD, discusses options for patients with hepatocellular carcinoma (HCC) who cannot undergo resection or transplant.

Louis B. Harrison, discusses the recent opportunities to combine radiation therapy and immunotherapy.

Mahmoud Al-Hawary, MD, discusses the current NCCN guidelines for imaging and how they play a role in patients with pancreatic cancer.

Tuya Pal, MD, discusses the importance of genetic risk assessment shaping management guidelines in ovarian cancer.

Jeffrey Jones, MD, discusses treatment options for patients with chronic lymphocytic leukemia (CLL) who progress on, or become intolerant of, idelalisib or ibrutinib during their treatment.

Eytan Stein, MD, discusses targeting multiple mutations in patients with acute myeloid leukemia (AML).